curium

Phase 3 Trial of Copper Cu 64 PSMA I&T PET/CT Imaging in Men with Suspected Biochemical Recurrence of Prostate Cancer (Solar-Recur)

Description:

Solar-Recur is a single-arm prospective study. Local read of the copper Cu 64 PSMA I&T PET/CT can be used to inform patient management. For the primary endpoints, PET/CT scans will be read by blinded independent reviewers.

Sponsor:

Curium

Contacts:

Darcy Denner, Ph.D. (Clinical Trial Director)

darcy.denner@curiumpharma.com

Inclusion
  • BCR of PC: Patients w/prior RP: PSA >.2 ng/mL w/confirm PSA value >.2, or w/prior radiation: 2ng/mL PSA rise over nadir
  • Male aged ≥18 years
  • Prior RP (>6 weeks prior to screening) or radiation therapy (>1 year prior to screening) with curative intent
  • Histologically proven prostate adenocarcinoma
Exclusion
  • ADT or other therapies targeting the Androgen pathway within 3 months. Pts w/rise in PSA while on ADT for >6 months
  • PSMA PET within 90 days prior to enrollment

Publications


Publications Not Yet Provided

Locations


United States 🇺🇸

XCancer - Omaha

17607 Gold Plaza, Omaha, Nebraska 68130, United States

Principal Investigator

Luke T. Nordquist, MD

View Profile

Carolina Urologic Research Center

Myrtle Beach, South Carolina, United States

Principal Investigator

Neal Shore, MD

View Profile

Weill Cornell Medicine at New York - Presbyterian

New York, New York 10021, United States

Principal Investigator

Scott Tagawa, MD


University of Iowa Medical Center

Iowa City, Iowa, United States

Principal Investigator

Janet Pollard, MD


Medical University of South Carolina

Charleston, South Carolina 29425, United States

Principal Investigator

Stephen Savage, MD


Boston VA

Boston, Massachusetts, United States

Principal Investigator

Yamin Dou, MD


University of Arizona Medical Center

Tucson, Arizona, United States

Principal Investigator

Bital Savir-Baruch, MD


Florida Urology Partners, LLP

Tampa, Florida 33607, United States

Principal Investigator

Osvaldo Padron, MD


VA Greater Los Angeles Healthcare System

Los Angeles, California, United States

Principal Investigator

Gholam Berenji, MD


Cleveland Clinic Florida

Weston, Florida, United States

Principal Investigator

Darko Pucar, MD


University of Maryland Greenebaum Cancer Center

Baltimore, Maryland, United States

Principal Investigator

Arif Hussain, MD


University of Tennessee Medical Center

Knoxville, Tennessee 37920, United States

Principal Investigator

Wesley White, MD


James J Peters VA Medical Center

Bronx, New York, United States

Principal Investigator

Isak Faiena, MD


Cleveland Clinic Ohio

Cleveland, Ohio, United States

Principal Investigator

Paresh Mahajan, MD


Hoag Memorial Hospital Presbyterian

Newport Beach, California, United States

Principal Investigator

Gary Ulaner, MD


SSM Saint Louis University Hospital

St. Louis, Missouri 63104, United States

Principal Investigator

Medhat Osman, MD, PhD - SLU


Providence Saint John's Health Center

Santa Monica, California 90404, United States

Principal Investigator

Przemyslaw Twardowski, MD


San Francisco VA Health Care System

San Francisco, California 94121, United States

Principal Investigator

Samuel Washington, MD


Edward Hines Jr. VA Health Care System

Hines, Illinois, United States

Principal Investigator

Nicholas Friedman, MD


Icahn School of Medicine at Mount Sinai

New York, New York, New York 10024, United States

Principal Investigator

Nasrin Ghesani, MD


John Cohchran VA St. Louis Health Care System

St. Louis, Missouri, United States

Principal Investigator

Medhat Osman, MD, PhD


Beverly Hills Cancer Center

Los Angeles, California, United States

Principal Investigator

Afshin Gabayan, MD


Urology of Indiana

Danville, Indiana, United States

Principal Investigator

Ronald Suh, MD


Great Plains Health

North Platte, Nebraska, United States

Principal Investigator

Ladd Lake, MD


Urology San Antonio

San Antonio, Texas 78229, United States

Principal Investigator

Daniel Saltzstein, MD


University of North Carolina Chapel Hill

Chapel Hill, North Carolina, United States

Principal Investigator

Steven Rowe, MD, PhD


Medstar Georgetown University Hospital

Washington, District of Columbia, United States

Principal Investigator

Paul Leger, MD


Providence Medical Foundation

Fullerton, California 92835, United States

Principal Investigator

Sanjay Sharma, MD


Excel Diagnostics & Nuclear Oncology Center

Houston, Texas, United States

Principal Investigator

Kanwal Siddiqui, MD


Urology Clinics of North Texas

Dallas, Texas, United States

Principal Investigator

Wilson Hernandez, MD


University of California Irvine Chao Family Comprehensive Cancer Center

Orange, California, United States

Principal Investigator

Edward Uchio, MD


Stanford University Medical Center

Stanford, California 94305, United States

Principal Investigator

Farshad Moradi, MD


Columbia University Medical Center - Herbert Irving Pavilion

New York, New York, United States

Principal Investigator

Mark Stein, MD


Washington University School of Medicine

St. Louis, Missouri, United States

Principal Investigator

Barry Siegel, MD


Biogenix Molecular LLC

Miami, Florida 33165, United States

Principal Investigator

Frankis Almaguel, MD


Portland VA Medical Center

Portland, Oregon, United States

Principal Investigator

Julie Graff, MD


Queens Hospital Center

Queens, New York, United States

Principal Investigator

Isuru Jayarantna, MD


Indiana University School of Medicine

Indianapolis, Indiana, United States

Principal Investigator

Mark Tann, MD


University of Minnesota

Minneapolis, Minnesota, United States

Principal Investigator

Emmanuel Antonarakis, MD


University of Kansas Cancer Center

Kansas City, Kansas, United States

Principal Investigator

William Parker, MD


University of Miami Miller School of Medicine-Sylvester Cancer Center

Miami, Florida, United States

Principal Investigator

Russ Kuker, MD


Minnesota Oncology

Maplewood, Minnesota, United States

Principal Investigator

Ryan Funk, MD


SUNY Upstate Medical Center

Syracuse, New York, United States

Principal Investigator

Gennady Bratslavsky, MD


University of California, San Francisco

San Francisco, California 94158, United States

Principal Investigator

Samuel Washington, MD - UCSF


Arkansas Urology

Little Rock, Arkansas, United States

Principal Investigator

Jeffrey Marotte, MD


Tower Urology

Los Angeles, California 90048, United States


XCancer

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468